Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 31.08.2026 1 Abdom Radiol (NY) 1 AIDS 1 Am J Manag Care 1 Anal Cell Pathol (Amst) 1 ANS Adv Nurs Sci 1 Arch Virol 7 Asian Pac J Cancer Prev 2 BMC Cancer 1 BMC Palliat Care 1 BMJ Case Rep 1 Braz J Med Biol Res 1 Cancer Biomark 1 Cancer Genet 1 Cancer Med 2 Cancer Treat Res Commun 6 Cancers (Basel) 1 Cell Signal 1 Cells 1 Chem Commun (Camb) 1 Clin Transl Oncol 1 Comput Methods Biomech Biomed Engin 1 Crit Rev Oncol Hematol 2 Cureus 1 Evid Based Nurs 1 FASEB Bioadv 1 Front Bioinform 1 Front Cell Dev Biol 4 Front Oncol 1 Front Pharmacol 1 Front Public Health 1 Gynecol Obstet Fertil Senol 1 Gynecol Oncol Rep 1 Health Commun 1 IEEE Trans Biomed Eng 1 Int J Environ Res Public Health 1 Int J Gynaecol Obstet 2 Int J Gynecol Cancer 2 Int J Mol Sci 1 Int J Qual Health Care 1 Int J Womens Health 2 J Cancer Educ 1 J Gynecol Obstet Hum Reprod 1 J Homosex 1 J Int Med Res 1 J Mol Diagn 1 J Multidiscip Healthc 1 J Nepal Health Res Counc 1 J Obstet Gynaecol India 2 J Vis Exp 1 JAMA Intern Med 1 JAMA Netw Open 1 Klin Onkol 1 Life (Basel) 3 Med Sci (Basel) 2 Medicina (Kaunas) 3 Medicine (Baltimore) 2 Mol Biol Rep 1 N Z Med J 1 Obstet Gynecol Res 1 Onco Targets Ther 2 Oncol Res 1 Osong Public Health Res Perspect 1 Pak J Pharm Sci 2 Pathogens 4 PLoS One 1 Proc (Bayl Univ Med Cent) 1 Proc Natl Acad Sci U S A 1 Radiother Oncol 1 Reprod Sci 5 Taiwan J Obstet Gynecol 1 Tech Innov Patient Support Radiat Oncol 1 Tohoku J Exp Med 1 Transl Oncol 1 Vaccines (Basel)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Abdom Radiol (NY)

1. ZHANG T, Fan W, Liu K, Xu H, et al
   Correction: Time-dependent diffusion MRI for assessing tumor microstructure and prognostic risk factors in cervical cancer.
   Abdom Radiol (NY). 2026 Aug 17. doi: 10.1007/s00261-026-05757.
   PubMed        
   
   

   
   AIDS

2. HARRIS DA, Germano Toledo R, Hacker M, Wamakima B, et al
   Persistent or recurrent cervical dysplasia in women living with HIV after treatment for high-grade dysplasia in Botswana.
   AIDS. 2026 May 26. doi: 10.1097/QAD.0000000000004551.
   PubMed         Abstract available
   
   

   
   Am J Manag Care

3. BUIST DSM, Smith RA, Fendrick AM
   Aligning the stars: quality metrics must evolve from screening rates to diagnostic resolution.
   Am J Manag Care. 2026;32:376-379.
   PubMed         Abstract available
   
   

   
   Anal Cell Pathol (Amst)

4. GUO R, He W, Liu X, Zhang N, et al
   Deciphering HPV-Associated Immune Evasion in Cervical Cancer Through Multi-Omics Profiling and Computational Screening.
   Anal Cell Pathol (Amst). 2026;2026:e6756766.
   PubMed         Abstract available
   
   

   
   ANS Adv Nurs Sci

5. SERGISON JE, Velickoff L, Hepler B, Knisley M, et al
   Trust-Building Across Levels of Care: A Conceptual Framework for Nursing Practice.
   ANS Adv Nurs Sci. 2026;49:105-111.
   PubMed         Abstract available
   
   

   
   Arch Virol

6. GROSS S, Dalphin L, Dor F, Ramanah R, et al
   Frequent detection of high-risk HPV types other than HPV 16/18 in a cohort of French women who claimed to have been vaccinated.
   Arch Virol. 2026;171:262.
   PubMed         Abstract available
   
   

   
   Asian Pac J Cancer Prev

7. PITAKKARNKUL S, Khomphaiboonkij U, Tangjitgamol S, Srisomboon J, et al
   Knowledge, Attitude, and Clinical Practice of HPV Vaccination and Cervical Cancer Screening: A National Survey of OB-GYN Practitioners in Thailand.
   Asian Pac J Cancer Prev. 2026;27:3097-3103.
   PubMed         Abstract available
   
   
8. SAHOO SS, Kumar P, Kumar R, Ludhiadch A, et al
   Content Quality of YouTube Videos on Human Papillomavirus Vaccine: A Systematic Analysis.
   Asian Pac J Cancer Prev. 2026;27:3029-3036.
   PubMed         Abstract available
   
   
9. MUCHTARIZA S, Masnarivan Y, Ilmaskal R
   Predictors of Cervical Cancer Screening Uptake Among Women of Reproductive Age in Indonesia: A Nationwide Cross-Sectional Study Based on the 2023 Indonesian Health Survey.
   Asian Pac J Cancer Prev. 2026;27:3013-3020.
   PubMed         Abstract available
   
   
10. ARMERINAYANTI NW, Lestari DPO, Wiguna IGWW
    MicroRNA-21 (miR-21), Mutant Tumor Protein p53, and Matrix Metalloproteinase-9 (MMP-9) as Risk Markers for High-Grade Tumor Budding (HGTB) in Cervical Carcinoma: A Case-Control Study in a Balinese Population.
    Asian Pac J Cancer Prev. 2026;27:2931-2940.
    PubMed         Abstract available
    
    
11. MILAMBO MJP, Giyosi N, Jafta Z, Ngxola N, et al
    Intersecting Burdens: HIV Prevalence and Cervical Cancer Progression Among Women in the Eastern Cape, South Africa: A Retrospective Descriptive Study.
    Asian Pac J Cancer Prev. 2026;27:2795-2801.
    PubMed         Abstract available
    
    
12. URUNDAI MEERAN SB
    Enhanced Diagnosis of Cervical Cancer Using Archer Fish Hunting Optimizer-Optimized Xception Network with AI Interpretability via Grad-CAM.
    Asian Pac J Cancer Prev. 2026;27:2783-2793.
    PubMed         Abstract available
    
    
13. AHMAD MU, Shaikh FN, Khan TM
    Methodological and Theoretical Considerations Regarding a Study on Cervical Cancer Screening Practices in Pakistan.
    Asian Pac J Cancer Prev. 2026;27:2747-2748.
    PubMed        
    
    

    
    BMC Cancer

14. ZHANG Y, Chen S, Jiang Y, Zhang L, et al
    A combined PAX1/JAM3 methylation and HPV viral load model for exploratory risk stratification of >/=CIN2 among women with positive cervical screening results.
    BMC Cancer. 2026;26:1029.
    PubMed         Abstract available
    
    
15. CHEN R, Gan Q, Zhao S, Zhang D, et al
    Retraction Note: DNA methylation of miR?138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2.
    BMC Cancer. 2026;26:1026.
    PubMed        
    
    

    
    BMC Palliat Care

16. DERIBE KS, Shewaye S, Habtamu NS, Wondimagegnehu A, et al
    Multi-level determinants of comprehensive palliative care delivery for breast and cervical cancer patients in Ethiopia: using the socio-ecological model as an analytical framework.
    BMC Palliat Care. 2026;25:257.
    PubMed         Abstract available
    
    

    
    BMJ Case Rep

17. HEALSMITH S, Foster L, Chard J, Brand A, et al
    Cisplatin-induced sarcoidosis-like reaction after primary chemoradiotherapy for locally advanced cervical cancer.
    BMJ Case Rep. 2026;19:e271654.
    PubMed         Abstract available
    
    

    
    Braz J Med Biol Res

18. SONG J, Zhao Y, Dong C, Qi X, et al
    Bulk and single cell RNA sequencing data reveal lactylation-related gene signatures for prognosis and immunity in cervical cancer.
    Braz J Med Biol Res. 2026;59:e15368.
    PubMed         Abstract available
    
    

    
    Cancer Biomark

19. LYU T, Li M, Li H, He L, et al
    Integrated multiparametric ultrasound and biomarker assessment for clinical staging and treatment response prediction in cervical cancer: A single-center retrospective study.
    Cancer Biomark. 2026;43:18758592261479724.
    PubMed         Abstract available
    
    

    
    Cancer Genet

20. CAI L, Jiang Y, Gu L, Li F, et al
    eIF3A Promotes the Warburg Effect in Cervical Cancer through m(6)A-dependent Translational Regulation of ENO1.
    Cancer Genet. 2026;308-309:15-29.
    PubMed         Abstract available
    
    

    
    Cancer Med

21. SARVESWARAN G, Ramraj A, Sankarapillai J, Punathil S, et al
    Harmonization Framework for Translating Clinical Cancer Staging Systems for Public Health and Surveillance Use in Low- and Middle-Income Countries: Validation Using Indian Cancer Registry Data.
    Cancer Med. 2026;15:e72184.
    PubMed         Abstract available
    
    

    
    Cancer Treat Res Commun

22. F G, J H, L SJ, P H, et al
    Association between body mass index and high grade cervical intraepithelial neoplasia (CIN 2/3) in a dysplasia referral population.
    Cancer Treat Res Commun. 2026;48:101279.
    PubMed         Abstract available
    
    
23. PEYDAYESH M, Nikfar S, Ghasemi K, Zamani N, et al
    Diagnostic performance of pap smear for cervical intraepithelial neoplasia in women with treatment-resistant vaginal infections: A colposcopy-guided biopsy correlated study.
    Cancer Treat Res Commun. 2026;48:101237.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

24. GIERULSKA N, Dabrowska Z, Jankowska N, Piekarz J, et al
    Targeted Anti-TF Antibody-Drug Conjugates in Advanced Cervical Cancer-Tisotumab Vedotin-Systematic Review.
    Cancers (Basel). 2026;18:2685.
    PubMed         Abstract available
    
    
25. RAYA-BAHENA T, Rivera-Escobar RM, Hernandez-Gallegos E, Jimenez-Salazar JE, et al
    Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies.
    Cancers (Basel). 2026;18:2589.
    PubMed         Abstract available
    
    
26. LIVERANI C, Boero V, Monti E, Caia C, et al
    Clinical Impact of HPV Self-Sampling and Molecular Biomarkers on Cervical Cancer Screening and Triage: "The Times They Are A-Changin'"-A Comprehensive Review and Future Perspectives.
    Cancers (Basel). 2026;18:2576.
    PubMed         Abstract available
    
    
27. D'AVENIA M, Muhr LSA, Mastromauro M, Spadaccino F, et al
    Relative HPV Viral Load Measured by DeltaCt for Risk Stratification in Cervical Cancer Screening.
    Cancers (Basel). 2026;18:2568.
    PubMed         Abstract available
    
    
28. YE Y, Fu Z, Wang X, Deng S, et al
    Study on the Expression Level of CAVIN3 Gene and the Prognosis of Radiotherapy in Patients with Cervical Cancer.
    Cancers (Basel). 2026;18:2551.
    PubMed         Abstract available
    
    
29. KAMO N, Soeda S, Honda T, Fujimori K, et al
    Immune Absence as a Proposed Framework for Delayed Relapse After Curative-Intent Treatment in Human Papillomavirus-Associated Cervical Cancer.
    Cancers (Basel). 2026;18:2530.
    PubMed         Abstract available
    
    

    
    Cell Signal

30. OU H, Chen W, Xiong Y
    HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer.
    Cell Signal. 2026;148:112840.
    PubMed         Abstract available
    
    

    
    Cells

31. PRAPAN A, Aissara P, Soonthornchookiat P, Suwannasing C, et al
    Dihydroquinine Enhances Radiosensitivity in Cervical Cancer Cells Accompanied by Radiation-Induced Cellular Responses.
    Cells. 2026;15:1484.
    PubMed         Abstract available
    
    

    
    Chem Commun (Camb)

32. YANG Z, Chen S, Liu X, Chen Y, et al
    Colorimetric analysis of metabolic biomarkers from unprocessed urine for rapid, at-home diagnosis of cervical cancer.
    Chem Commun (Camb). 2026 Aug 25. doi: 10.1039/d6cc03906.
    PubMed         Abstract available
    
    

    
    Clin Transl Oncol

33. AL AWFI MMM, Al Wahaibi ASIS, Arafa M, Al Badi H, et al
    Assessing telomerase and Ki-67 protein expression in pre-invasive lesions and invasive cervical neoplasia with correlation to clinico-pathological parameters.
    Clin Transl Oncol. 2026;28:3880-3896.
    PubMed         Abstract available
    
    

    
    Comput Methods Biomech Biomed Engin

34. FU Y, Du L, Zhang H, Wan J, et al
    Comprehensive analysis of senescence-associated secretory phenotype-related signature for predicting prognosis and immunotherapy response in cervical cancer.
    Comput Methods Biomech Biomed Engin. 2026.
    PubMed         Abstract available
    
    

    
    Crit Rev Oncol Hematol

35. IQBAL H, Abuwatfa WH
    Immunological consequences of mesenchymal stem cell therapy in HPV-driven cervical cancer: a systematic review and stratification framework.
    Crit Rev Oncol Hematol. 2026 Aug 27:105570.
    PubMed         Abstract available
    
    

    
    Cureus

36. SHASHIKANT, Raghuvanshi R, Ali M, Meena H, et al
    Utility of Serum Vascular Endothelial Growth Factor and Its Clinico-Histopathological Correlation With Cervical Cancer: A Tertiary Care Centre Study.
    Cureus. 2026;18:e113209.
    PubMed         Abstract available
    
    
37. USMANI S, Ahmed N, Burney IA, Kheruka S, et al
    Advances in Positron Emission Tomography Combined With Computed Tomography (PET/CT) Imaging in Cervical Cancer: From Metabolic Assessment to Fibroblast Activation Protein-Targeted Imaging.
    Cureus. 2026;18:e113158.
    PubMed         Abstract available
    
    

    
    Evid Based Nurs

38. MORADI S
    Addressing the hidden epidemic: the critical need for comprehensive psycho-oncology in cervical cancer.
    Evid Based Nurs. 2026 Aug 26:ebnurs-2026-104741. doi: 10.1136/ebnurs-2026-104741
    PubMed        
    
    

    
    FASEB Bioadv

39. CHAN HCC, Bhoora S, Zhou E, Marais S, et al
    Supraphysiological 25-Hydroxyvitamin D(3) and Calcipotriol Induce Reactive Oxygen Species, Mitochondrial Dysfunction and Apoptosis in HeLa Cervical Cancer Cells.
    FASEB Bioadv. 2026;8:e70144.
    PubMed         Abstract available
    
    

    
    Front Bioinform

40. LIU C, Ji C
    AI-enhanced virtual screening identifies a potent small-molecule modulator of ClC-3 for cervical cancer drug discovery.
    Front Bioinform. 2026;6:1887419.
    PubMed         Abstract available
    
    

    
    Front Cell Dev Biol

41. LIU Y, Yin D, Wu L, Wang H, et al
    Single-cell transcriptomics reveals a correlation between inflammatory C7 fibroblasts in cervical tumor-adjacent normal tissues and cervical cancer progression.
    Front Cell Dev Biol. 2026;14:1829843.
    PubMed         Abstract available
    
    

    
    Front Oncol

42. SAHU U, Singh S, Jain S, Samant M, et al
    Recent advancement in inflammatory biomarkers for cervical cancer diagnosis and therapy.
    Front Oncol. 2026;16:1806448.
    PubMed         Abstract available
    
    
43. MONDAL J, Chatterjee R, Gourisaria MK, Sahni M, et al
    Multi-plane attention guided 3D nnU-Net for MRI-based cervical cancer segmentation.
    Front Oncol. 2026;16:1862510.
    PubMed         Abstract available
    
    
44. GALVIS I, Hafeez A, Philip J, Salvatore M, et al
    The oncogenic role of mir-21 in cervical cancer: linking epithelial-mesenchymal transition to stromal remodeling.
    Front Oncol. 2026;16:1814515.
    PubMed         Abstract available
    
    
45. REZA HM, Azhari HA, Chowdhury O, Bepari AK, et al
    Integrating pocket colposcope and telecolposcopy into VIA-based screening at primary healthcare centers for cervical cancer prevention in LMICs.
    Front Oncol. 2026;16:1902305.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

46. SHEN Y, Lu S, Zhao Q, Cui T, et al
    Targeting RSF1 with tanshinone I inhibits cervical cancer cell growth through modulation of NF-kappaB pathway.
    Front Pharmacol. 2026;17:1855194.
    PubMed         Abstract available
    
    

    
    Front Public Health

47. BOTSUN P, Omelianenko I, Sava Y, Panko M, et al
    Cervical screening under wartime: resilience and quality of laboratory services in Ukraine during the Russian invasion.
    Front Public Health. 2026;14:1909774.
    PubMed         Abstract available
    
    

    
    Gynecol Obstet Fertil Senol

48. MONGE L, Blin A, Yousfi C, Mariotti S, et al
    [Preventing human papillomavirus in middle school: The role of an Escape Game].
    Gynecol Obstet Fertil Senol. 2026;54:417-424.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol Rep

49. YASUKAWA M, Kohut A, Joseph DC, Miller J, et al
    Peri-treatment ctDNA dynamics in locally advanced cervical cancer: pilot study from a safety-net hospital.
    Gynecol Oncol Rep. 2026;66:102186.
    PubMed         Abstract available
    
    

    
    Health Commun

50. MCKENZIE AH, Zinzow HM, Kettrey HH, Baker AM, et al
    Barriers and Facilitators for Cervical and Breast Cancer Screenings Among Survivors of Gender-Based Violence.
    Health Commun. 2026;41:1811-1820.
    PubMed         Abstract available
    
    

    
    IEEE Trans Biomed Eng

51. TRUMPOUR T, Nasser J, Bax J, Gardi L, et al
    An Automated Mechatronic System for Registration of Three-Dimensional Ultrasound Images in Cervical Brachytherapy Procedures.
    IEEE Trans Biomed Eng. 2026;73:3249-3258.
    PubMed         Abstract available
    
    

    
    Int J Environ Res Public Health

52. VASQUEZ GUZMAN CE, Rosenkranz SJ, Martinez C, Layman KA, et al
    "It Feels Like They Cut off My Wings": Cervical Cancer Stories and Experiences Among Middle- to Older-Age Latina Survivors in the United States.
    Int J Environ Res Public Health. 2026;23:992.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

53. SHEN J, Liao J, Wang J, Xing H, et al
    Automated acquisition of explainable knowledge from unannotated colposcopic images for predicting the natural course of CIN2.
    Int J Gynaecol Obstet. 2026;174:1547-1558.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

54. MARTINS JC, Gomes Silva BG, de Mello Graziano L, Scaranti M, et al
    Does timing matter? Rethinking immunotherapy strategies in locally advanced cervical cancer.
    Int J Gynecol Cancer. 2026 Aug 4:104944. doi: 10.1016/j.ijgc.2026.104944.
    PubMed        
    
    
55. CHILINDA GK, Meja SJ, Kocian R, Mirandola M, et al
    Implementation of a gynecologic oncology ultrasound training program to support cervical cancer staging at Queen Elizabeth Central Hospital in Malawi.
    Int J Gynecol Cancer. 2026;36:104906.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

56. TAIZHANOVA D, Serikbay N, Casas PHFDCL, Mijucic J, et al
    Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer.
    Int J Mol Sci. 2026;27:7302.
    PubMed         Abstract available
    
    
57. PEPE L, Zuccala V, Giordano WG, Di Mauro G, et al
    Liquid Biopsy for Minimal Residual Disease Assessment in Endometrial and Cervical Cancers: Molecular Rationale, Clinical Evidence, and Translational Barriers.
    Int J Mol Sci. 2026;27:7155.
    PubMed         Abstract available
    
    

    
    Int J Qual Health Care

58. CHONGSUWAT T, Nana A, Ibrahim AO, Evensen AE, et al
    Assessment of Knowledge, Attitudes, and Practices around Cervical Cancer Screening in the Gulu District of Northern Uganda: A cross-sectional study.
    Int J Qual Health Care. 2026 Aug 24:mzag118. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Womens Health

59. ZHU M, Shen F, You J, Li J, et al
    Risk Factors for Occult Invasive Cervical Cancer in Women with Abnormal Cervical Screening and Infeasible Diagnostic Conization.
    Int J Womens Health. 2026;18:621098.
    PubMed         Abstract available
    
    

    
    J Cancer Educ

60. WAKUI N, Koakutsu Y, Watanabe M, Yokoyama Y, et al
    HPV Education and Its Impact on Vaccination Willingness and Recommendation Intentions Among Unvaccinated Japanese University Students: A Cross-Sectional Study.
    J Cancer Educ. 2026;41:787-793.
    PubMed         Abstract available
    
    
61. RAI I, Karkala E, Borgaonkar R, Seide J, et al
    Call for Increased Community Education Regarding Common HPV-Associated Cancers Within the Urban Safety-Net Hospital Population.
    J Cancer Educ. 2026;41:753-761.
    PubMed         Abstract available
    
    

    
    J Gynecol Obstet Hum Reprod

62. DABI Y, Martinez A, Lacorre A, Touboul C, et al
    SURGICAL NODAL STAGING IN CERVICAL CANCER, A NARRATIVE REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Aug 25:103260.
    PubMed         Abstract available
    
    

    
    J Homosex

63. YU W, Smith Z
    Sexual and Gender Minorities' Experience with Cervical Cancer Screening: A Systematic Review of Qualitative Studies.
    J Homosex. 2026 Aug 27:1-30. doi: 10.1080/00918369.2026.2715436.
    PubMed         Abstract available
    
    

    
    J Int Med Res

64. CHEN X, Zhang L, Luo J
    Predictive value of triglyceride combined with age-adjusted D-dimer in patients with early-stage cervical cancer.
    J Int Med Res. 2026;54:3000605261476782.
    PubMed         Abstract available
    
    

    
    J Mol Diagn

65. HAWKES D, Gurung D, Pineda E, Lee A, et al
    Clinical Validation of the Roche cobas and cobas 4800 Human Papillomavirus Tests on Self-Collected Vaginal Dry Swabs versus Practitioner-Collected Cervical Specimens Using the VALHUDES Protocol.
    J Mol Diagn. 2026;28:665-672.
    PubMed         Abstract available
    
    

    
    J Multidiscip Healthc

66. HU Y, Li J, Zhu S, Cheng L, et al
    Knowledge, Attitudes, and Practices Related to Radiotherapy and Chemotherapy Among Women with Cervical Cancer: A Cross-Sectional Study.
    J Multidiscip Healthc. 2026;19:624433.
    PubMed         Abstract available
    
    

    
    J Nepal Health Res Counc

67. GUPTA RK, Shrestha K, Bhandari B, Manandhar B, et al
    Human Papillomavirus (HPV) Proportion and Genotype Distribution among Reproductive age Women of a Hilly District of Nepal.
    J Nepal Health Res Counc. 2026;24:109-115.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol India

68. GARG R, Agarwal K, Dhiman N, Gandhi G, et al
    Comparison of Conventional Pap Smear and Liquid-Based Cytology in the detection of Cervical Intraepithelial Neoplasia and Cervical Cancer.
    J Obstet Gynaecol India. 2026;76:291-297.
    PubMed         Abstract available
    
    

    
    J Vis Exp

69. XING T, Liu H, Yu W, Ren L, et al
    Drug Resistance and Therapeutic Reversal Strategies in Ovarian, Cervical, and Endometrial Cancers.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    
70. GAO M, Wu L, Liu M, Liu W, et al
    Human Wings Apart-Like Protein as a Serum Diagnostic Biomarker in Cervical Cancer: An Integrative Bioinformatics Analysis with Serum Validation.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    

    
    JAMA Intern Med

71. HOLT HK, Kislovskiy Y, Sawaya GF
    Cervical Cancer Screening Updates-Focus on Self-Collected Primary Human Papillomavirus Testing.
    JAMA Intern Med. 2026 Aug 24. doi: 10.1001/jamainternmed.2026.3980.
    PubMed        
    
    

    
    JAMA Netw Open

72. SONAWANE K, Damgacioglu H, Amboree TL, Ford ME, et al
    Rates of Never Receiving Cervical Cancer Screening Among US Women, 2005-2023.
    JAMA Netw Open. 2026;9:e2631550.
    PubMed        
    
    

    
    Klin Onkol

73. JURIKOVA ZM, Hernychova L
    HPV infection and its significance in the development and prevention of cervical cancer.
    Klin Onkol. 2026;39:262-265.
    PubMed         Abstract available
    
    

    
    Life (Basel)

74. PEREIRA GM, Calfa S, Santos PRD, Freitas AJA, et al
    MicroRNA Dysregulation in HPV-Driven Cervical Cancer: A Review of Oncoprotein-Targeted Signaling Pathways.
    Life (Basel). 2026;16:1332.
    PubMed         Abstract available
    
    

    
    Med Sci (Basel)

75. PATERNOSTRO C, Joura E, Nowotny G, Langthaler EM, et al
    Incidence and Risk Factors of Postoperative Bleeding After LLETZ.
    Med Sci (Basel). 2026;14:478.
    PubMed         Abstract available
    
    
76. NATI ID, Mihu CM, Mihu D, Ciortea R, et al
    The Cervical Cancer Paradox in Eastern Europe: How Knowledge and Institutional Trust Shape HPV Vaccination Attitudes in Romania.
    Med Sci (Basel). 2026;14:431.
    PubMed         Abstract available
    
    
77. NATI ID, Oancea M, Mihu CM, Mihu D, et al
    Agreement and Diagnostic Performance of Urinary HPV Testing Versus Clinician-Collected Cervico-Vaginal Sampling: A Prospective Cross-Sectional Study in a Romanian Cohort.
    Med Sci (Basel). 2026;14:423.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

78. RONSINI C, Di Nuzzo A, Solazzo MC, Scaffa C, et al
    Exploratory Analysis of Systemic Inflammatory Indices Across Locoregional Tumor Progression Parameters in Cervical Cancer: The CERTIFIKO Prospective Study.
    Medicina (Kaunas). 2026;62:1570.
    PubMed         Abstract available
    
    
79. ZIVADINOVIC AR, Petric AN, Zivadinovic LR, Ilic IR, et al
    Clinical Significance of High-Risk HPV Positivity with Negative Cytology: Can Further Evaluation Be Safely Delayed?
    Medicina (Kaunas). 2026;62:1493.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

80. DENG X, Pang X, Dai Z
    Nursing intervention and follow-up compliance after abnormal cervical cancer screening.
    Medicine (Baltimore). 2026;105:e49893.
    PubMed         Abstract available
    
    
81. TIBENDERANA JR, Kessy SA, Gimonge J, Peter I, et al
    Cervical cancer screening predictors in Tanzania: a variance component models' approach of national survey 2022.
    Medicine (Baltimore). 2026;105:e50260.
    PubMed         Abstract available
    
    
82. ZHANG Q, Lin Y, Bao L, Huang Q, et al
    Analysis of the clinical utility of p16/Ki-67 dual staining in screening cervical lesions among women positive for high-risk HPV.
    Medicine (Baltimore). 2026;105:e50102.
    PubMed         Abstract available
    
    

    
    Mol Biol Rep

83. SINGH P, Bhushan B, Kumar A, Misra G, et al
    Integrating non-coding RNA profiling with HPV genotyping for cervical cancer risk stratification and early detection.
    Mol Biol Rep. 2026;53:1482.
    PubMed         Abstract available
    
    
84. MASOOD S, Rajawat J, Kumar M, Singh G, et al
    PARP1 genetic variants modulate gene expression and cervical cancer susceptibility in a North Indian case-control study.
    Mol Biol Rep. 2026;53:1470.
    PubMed         Abstract available
    
    

    
    N Z Med J

85. GREGORY K, Iosua E, Signal V, Neumann R, et al
    Aotearoa New Zealanders' views of policies and funding for human papillomavirus vaccination and screening for cervical and lung cancers: a national survey.
    N Z Med J. 2026;139:69-78.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol Res

86. CHANG YC, McSweeney K, Xu Y, Liu Y, et al
    A Cell-Penetrating Peptide and Signal Sequence Fusion DNA Vaccine Enhances CD8+ T Cell-Mediated Anti-Tumor Immunity Targeting HPV-16 Cervical Cancer Antigens.
    Obstet Gynecol Res. 2026;9:54-63.
    PubMed         Abstract available
    
    

    
    Onco Targets Ther

87. COLAK R, Kapar C, Tacar SY, Degerli E, et al
    Prognostic Value of BMI in Patients with Metastatic Cervical Cancer:A Retrospective Study From Turkey.
    Onco Targets Ther. 2026;19:622194.
    PubMed         Abstract available
    
    

    
    Oncol Res

88. RAJ EN, Li CJ, Cheng SH, Yong SB, et al
    Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer.
    Oncol Res. 2026;34:18.
    PubMed         Abstract available
    
    
89. ZHAO D, Liu Q
    Cellular Immunotherapy for Cervical Cancer: Next Therapeutics Frontiers.
    Oncol Res. 2026;34:9.
    PubMed         Abstract available
    
    

    
    Osong Public Health Res Perspect

90. SIVAKUMAR I, Thirumalai J, Mohammed AAF
    Long-term trends and post-pandemic deviations in cervical cancer burden in South India, 1990-2023: a Global Burden of Disease 2023 study.
    Osong Public Health Res Perspect. 2026 Aug 26. doi: 10.24171/j.phrp.2026.0252.
    PubMed         Abstract available
    
    

    
    Pak J Pharm Sci

91. ZHOU R, Wang H, Li A, Lv S, et al
    MicroRNA-135 alleviates cisplatin resistance in cervical cancer by inhibiting CD44v6.
    Pak J Pharm Sci. 2026;39:3500-3514.
    PubMed         Abstract available
    
    

    
    Pathogens

92. PINTO V, Dellino M, Cerbone M, Di Naro E, et al
    The Role of Adjuvant Nonavalent HPV Vaccination After LLETZ in Patients with Isolated CIN2: A Controlled Cohort Study.
    Pathogens. 2026;15:814.
    PubMed         Abstract available
    
    
93. GONZALEZ-TOLENTINO DL, Garibay-Cerdenares OL, Encarnacion-Guevara S, Martinez-Batallar AG, et al
    Molecular Insights from Differential Proteomic Profiling of Premalignant Cervical Lesions and Cervical Cancer.
    Pathogens. 2026;15:793.
    PubMed         Abstract available
    
    

    
    PLoS One

94. KWESI-MALIEPAARD EM, Osea-Larbi JA, Nyamari CK, Alhassan Y, et al
    Genotype distribution of high-risk and potential high-risk HPV types among women in different screening and clinic settings in Ghana and Kenya.
    PLoS One. 2026;21:e0355868.
    PubMed         Abstract available
    
    
95. JIA M, Song Y, Shang J, Zhuang L, et al
    An interpretable Hallmark pathway activity classifier for distinguishing CIN3/HSIL from invasive cervical squamous carcinoma: Development, external validation, and feature stability assessment.
    PLoS One. 2026;21:e0356465.
    PubMed         Abstract available
    
    
96. DENG Q, Wang Z, Zhao J, Li N, et al
    HDAC2 restrains IGF2BP1-associated m6A dysregulation in cervical cancer immunotherapy resistance.
    PLoS One. 2026;21:e0355606.
    PubMed         Abstract available
    
    
97. MOSTAFA HH, Fall A, Gaillard S, Fakhry C, et al
    Application of Cobas 6800 HPV testing and qPCR utilizing three genomically-optimized primer sets for detecting HPV DNA in the blood of HPV Positive dysplasia and cancer patients.
    PLoS One. 2026;21:e0354671.
    PubMed         Abstract available
    
    

    
    Proc (Bayl Univ Med Cent)

98. SHIN R, Shin A, Ramirez M, Bondre IL, et al
    Supporting patient understanding of cervical and ovarian cancer: how well does AI perform?
    Proc (Bayl Univ Med Cent). 2026;39:832-836.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

99. LIU X, Shrestha SK, Edwards YJK, Filippova N, et al
    HuB/HuR inhibition decreases HPV E6 and E7 proteins, stabilizes p53, and induces integrated stress to impair cervical cancer cell growth.
    Proc Natl Acad Sci U S A. 2026;123:e2401248123.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

100. TSUCHIDA K, Ogawa K, Toita T, Ikushima H, et al
     Survival impact of pelvic radiotherapy plus chemotherapy in newly diagnosed stage IVB cervical cancer in Japan (JROSG22-1/JGOG1088S).
     Radiother Oncol. 2026 Aug 27:111752. doi: 10.1016/j.radonc.2026.111752.
     PubMed         Abstract available
     
     

     
     Reprod Sci

101. WANG X, Wang F, Yang W, Li Y, et al
     Weighted Gene Co-Expression Network Analysis and Machine Learning Reveal that USP1 Drives Lipid Metabolism and Macrophage Polarization in Cervical Cancer Cells.
     Reprod Sci. 2026 Aug 24. doi: 10.1007/s43032-026-02172.
     PubMed         Abstract available
     
     

     
     Taiwan J Obstet Gynecol

102. CHU HH, Tsai TC, Chen LH, Chang SD, et al
     Successful pregnancy outcome following fertility-sparing treatment for cervical cancer: A case report on the challenges of assisted reproductive techniques.
     Taiwan J Obstet Gynecol. 2026;65:995-999.
     PubMed         Abstract available
     
     
103. SUN YH, Huang JY, Kuo ES, Yang SF, et al
     Long-term risk of cancer following cervical intraepithelial neoplasia: A significant study leveraging Taiwan's national health insurance research database.
     Taiwan J Obstet Gynecol. 2026;65:974-981.
     PubMed         Abstract available
     
     
104. CHANG SH, Tang WJ, Chen WC, Chang CB, et al
     The addition of bevacizumab to combination chemotherapy in patients with recurrent, persistent, or metastatic cervical cancer: Aretrospective single-arm study.
     Taiwan J Obstet Gynecol. 2026;65:900-905.
     PubMed         Abstract available
     
     
105. WANG PH, Yang ST, Kim JH
     The evolving treatment paradigm of locally advanced cervical cancer (LACC) recurrent, advanced, metastatic and persistent (RAMP) cervical cancer.
     Taiwan J Obstet Gynecol. 2026;65:880-884.
     PubMed        
     
     
106. FANG MH, Wang KL, Lee J, Jan YT, et al
     Case report of an unusual cecal metastasis of a primary cervical squamous cell carcinoma.
     Taiwan J Obstet Gynecol. 2026;65:1008-1012.
     PubMed         Abstract available
     
     

     
     Tech Innov Patient Support Radiat Oncol

107. MEHTA A, Hegde AI, N P J, Velu U, et al
     Impact of qualitative Diffusion weighted imaging and apparent diffusion coefficient (DWI/ADC) on target volume delineation in cervical cancer: a feasibility study.
     Tech Innov Patient Support Radiat Oncol. 2026;39:100424.
     PubMed         Abstract available
     
     

     
     Tohoku J Exp Med

108. AOYAMA Y, Watanabe F, Tokutsu K, Muramatsu K, et al
     Association Between Japan's COVID-19 State of Emergency Declarations and Hospitalizations for Radiotherapy for Cervical Cancer.
     Tohoku J Exp Med. 2026 Aug 27. doi: 10.1620/tjem.2026.
     PubMed        
     
     

     
     Transl Oncol

109. YU P, Wei Y, Diao B, Sun C, et al
     STT3 promotes cervical cancer proliferation and apoptosis via PI3K/AKT pathway.
     Transl Oncol. 2026;72:102991.
     PubMed         Abstract available
     
     

     
     Vaccines (Basel)

110. LOUNIS M, Bencherit D, Abed M, Aissa ZB, et al
     Awareness and Knowledge Levels of Cervical Cancer and HPV and Attitudes Toward HPV Vaccination in Algeria.
     Vaccines (Basel). 2026;14:676.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum